|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Novo Nordisk A/S Common Stock [NVO]
$47.83 0.30 (0.64%)
Market Cap 112.37 Billion
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
EPS 4.37 P/E Ratio 18.42
Previous Earnings Fri, May 3, 2019
Latest Earnings Fri, Aug 9, 2019 (In 79 days)
Yield 3.29% / $1.58
Ex-Date Fri, Mar 22, 2019 (61 days ago)
Pay Date Tue, Apr 2, 2019
This list of trending stocks may change throughout the trading day.